Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 ...

The FDA has approved palbociclib (Ibrance) in combination with trastuzumab (Herceptin), endocrine therapy, and optionally ...

These results support darovasertib plus Xalkori as a potential new standard of care if approved for HLA A*02:01-negative ...

Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

Recurrence is common enough that all of us need to act on potential symptoms. Sometimes it’s impossible to remember what my life was like before cancer. After all, I’ve been living with metastatic ...

Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...

Eli Lilly launches Tanstrive, a targeted oral cancer therapy for RET-altered tumors, priced at ₹2.15 lakh for two weeks.

Metastatic breast cancer denotes distant organ involvement (e.g., liver, brain, bone) and typically changes therapeutic goals from eradication to survival prolongation and quality-of-life preservation ...